Y
Yanna Zhao
Researcher at Liaocheng University
Publications - 61
Citations - 834
Yanna Zhao is an academic researcher from Liaocheng University. The author has contributed to research in topics: Chemistry & Drug carrier. The author has an hindex of 14, co-authored 50 publications receiving 434 citations. Previous affiliations of Yanna Zhao include Peking Union Medical College.
Papers
More filters
Journal ArticleDOI
Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation
Yanna Zhao,Chang Cai,Min Liu,Yuping Zhao,Yushu Wu,Zhiping Fan,Zhuang Ding,Huaizhen Zhang,Zhengping Wang,Jun Han +9 more
TL;DR: The novel paclitaxel/resveratrol co-loaded albumin nanoparticles (PTX/RES NPs) co-delivery system might be a promising strategy for combined anticancer therapy to overcome tumor drug resistance.
Journal ArticleDOI
Influence of polysaccharide as co-encapsulant on powder characteristics, survival and viability of microencapsulated Lactobacillus paracasei Lpc-37 by spray drying
Tao Tao,Zhuang Ding,Danping Hou,Sangeeta Prakash,Yanna Zhao,Zhiping Fan,Demeng Zhang,Zhengping Wang,Min Liu,Jun Han +9 more
TL;DR: In this paper, five polysaccharides were selected as co-encapsulant of skim milk based matrix and used for the microencapsulation of Lactobacillus paracasei Lpc-37 by spray drying.
Journal ArticleDOI
Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo.
TL;DR: Hemolytic evaluation indicated MTX/PGD NPs presented good blood compatibility, and the cytotoxicity of nanoparticles against breast cancer cells in vitro, biodistribution in tumor tissue, and antitumor efficacy in vivo were enhanced significantly compared to MTX injection.
Journal ArticleDOI
Enhanced Oral Bioavailability of Celecoxib Nanocrystalline Solid Dispersion based on Wet Media Milling Technique: Formulation, Optimization and In Vitro/In Vivo Evaluation.
TL;DR: In this paper, the authors developed and optimized CLX nanocrystalline (CLX-NC) solid dispersion prepared by the wet medium millingtechnique combined with lyophilization to enhance oral bioavailability.
Journal ArticleDOI
Effect of plasticizers on manufacturing ritonavir/copovidone solid dispersions via hot-melt extrusion: Preformulation, physicochemical characterization, and pharmacokinetics in rats
Yanna Zhao,Xie Xuemei,Yuping Zhao,Yan Gao,Chang Cai,Qinxiu Zhang,Zhuang Ding,Zhiping Fan,Huaizhen Zhang,Min Liu,Jun Han +10 more
TL;DR: The in vitro release and the in vivo pharmacokinetics analyses both showed that RTV SD formulations using Span 20 or HSPC as plasticizer possessed better release profiles and bioavailability over RTV bulk powder but showed equal physicochemical characteristics compared to RTVSD formulations without plasticizer.